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A 58-year-old man, in whom an implantable cardiac deﬁbrillator (ICD) had been implanted for Brugada
syndrome, suffered rapidly progressive general paralysis. Various diagnostic imaging techniques were
performed, but the cause could not be determined. Magnetic resonance imaging (MRI) scanning was
performed. A 1.5-Tesla MRI system was used, and the ICD was programmed to ODO mode and all
tachycardia detection was turned off. MRI was performed safely under electrocardiogram and pulse
oximeter monitoring, and appropriate precautions were taken in preparation for an emergency. ICD
parameters did not change in post-imaging investigations. MRI revealed an apparent tumor in the
patient’s medulla and upper cervical spinal cord, which was diagnosed as high-grade astrocytoma.
When performing MRI procedures in patients with an ICD under urgent conditions, it is necessary to
have complete knowledge of the procedure and to make careful preparations.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Magnetic resonance imaging (MRI) is a diagnostic technique
that has become the imaging modality of choice for many
neurological and musculoskeletal disorders. However, a growing
number of patients are being treated with cardiac implantable
electric devices (CIEDs), such as pacemakers (PMs) and implan-
table cardiac deﬁbrillators (ICDs), and cardiac resynchronization
therapy. The use of MRI has been contraindicated in patients with
implanted CIEDs. However, MRI is sometimes necessary in these
patients for a variety of practical reasons. A number of cases of
MRI scanning in patients with PMs, and some cases in patients
with ICDs, have been reported in the United States and Europe
[1,2]; however, in Japan there are few reports on MRI use in
patients with PMs and, in particular, none on patients with ICDs.2. Case report
A 58-year-old man, who had been treated for neuroﬁbroma-
tosis type 1 in the dermatology department and bronchial asthma
in the respiratory department of our hospital, presented to the
cardiology department with a Brugada-like electrocardiogram
(ECG) in 2005. The patient’s brother had died from sudden death
at age 53. The baseline ECG was saddleback type, but intravenousrt Rhythm Society. Published by E
: þ81 76 234 4250.
usho MD).pilsicainide injection at 1 mg/kg induced a typical coved-type
ECG. Also in his electrophysiological assessment, ventricular
ﬁbrillation was induced by 2 extrastimuli from the right ventri-
cular apex. Familial Brugada syndrome was highly suspected and
an ICD was implanted. The device was exchanged in 2010 because
the battery had become exhausted.
In September 2011, the patient suffered right-sided paralysis,
which rapidly progressed to all 4 limbs, and was admitted to the
neurology department. His ECG showed a saddleback pattern in
the right precordial leads consistent with Brugada syndrome. An
ICD with an atrial lead and a dual-coil ventricular deﬁbrillation
lead was apparent on his chest radiograph (Fig. 1). To identify the
etiology of the paralysis, contrast-enhanced computed tomogra-
phy (CT), CT myelography, cerebral blood ﬂow scintigraphy, and
whole-body gallium scintigraphy were performed, but no obvious
abnormality was found. In the meantime, his condition worsened
and he experienced aspiration with swallowing disturbance;
steroid pulse therapy was administered to relieve the symptoms.
At this point, ﬂuorodeoxyglucose positron emission tomography
(FDG-PET)/CT was performed, and it showed obvious uptake at
the patient’s medulla to his upper cervical spinal cord, suggesting
the presence of a malignant tumor. To conﬁrm this diagnosis and
establish a treatment plan, we performed MRI. Written informed
consent containing the risks of this procedure including ICD
dysfunction or damage, fatal arrhythmia, and death was obtained
from the patient and his family.
The patient had an implanted Medtronic SECURA DR device
(atrial lead: Medtronic 6940/52 cm, ventricular lead: Medtroniclsevier B.V. All rights reserved.
Fig. 1. (A) Electrocardiogram and (B) chest radiograph on admission. The electrocardiogram showed a saddleback-type Brugada ECG. A dual-chamber ICD was apparent in
the left subclavian area, and an atrial lead and a dual-coil ventricular deﬁbrillation lead were connected to the ICD.
Fig. 2. Placement of monitors at the MRI console. The ECG monitor was displayed
on the main control screen; however, heart rhythm was not determinable during
scanning due to noise. The monitor of the pulse oximeter was placed so that it
could be seen from outside the room. Thus, the patient’s pulsatile rhythm was
monitored continuously during the study. A television monitor showed the
patient’s appearance.
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1.5-Tesla system. Before performing MRI, we referred to the
European position statement on MRI in patients with CIEDs [3].
Because sinus rhythm was maintained and ventricular tachycar-
dia was not experienced, we programmed the pacing mode of the
ICD to ODO and turned off all tachycardia detection. A radiology
technician, nurse, clinical engineer, radiologist, neurologist, and
cardiologist were present in the control booth. A device program-
mer, an external deﬁbrillator, and an emergency cart were set at
the MRI console. An ECG monitor, usually used for ECG synchro-
nization during MRI scanning, and a pulse oximeter were ﬁxed to
the patient. The pulse monitor was placed where it could be seen
from the control room. Furthermore, a television camera was
employed to monitor the patient’s appearance (Fig. 2).
Diffusion-weighted imaging (DWI), T2-weighted (T2W), ﬂuid-
attenuated inversion-recovery (FLAIR), and gadolinium-enhanced
T1-weighted (Gd-T1W) imaging protocols were performed duringthe examination. Because remote programming was available
with the patient’s ICD device, the intracardiac rhythm was
monitored until the patient entered the room; however, after
closing the door, remote monitoring was not possible. After
closing the door, ECG monitoring began. However, during MRI
scanning, the noise became loud enough to obscure the contin-
uous determination of the heart rhythm by ECG. The pulse
oximeter, however, showed the patient’s pulse continuously
during scanning. The patient showed no disturbance during the
study, and no ICD parameter changed signiﬁcantly just after or
1 week after the scan, when compared with the last pre-scan data.
Atrial pacing threshold was 1.0 V at a 0.4 ms pulse width before
MRI scanning, 1.0 V after scanning, and 0.75 V after 1 week.
Ventricular threshold was 0.5 V at a 0.4 ms pulse width, 0.75,
and 0.75 V before, just after, and 1 week after scanning, respec-
tively. In the same way, intrinsic atrial amplitude was 3.6, 3.6, and
3.8 mV, respectively. Intrinsic ventricular amplitude was 15.0,
15.1, and 12.9 mV, respectively. Atrial lead impedance was 494,
494, and 475O, respectively. Finally, ventricular lead impedance
was 437, 475, and 418O, respectively.
MRI revealed an apparent tumor in the patient’s medulla and
upper cervical spinal cord, with partial extension towards the
fourth ventricle (Fig. 3). The post-MRI diagnosis made was that of
a neurogliomatous tumor. Following these results, biopsy of the
tumor at the fourth ventricle was performed, and the tumor was
diagnosed as a grade III–IV astrocytoma. Subsequently, radio-
therapy was started in this patient.3. Discussion
We performed cranial to cervical MRI scanning safely in a
patient with ICD implantation who showed signs of central
neurological disease that could not be diagnosed by other imaging
techniques.
For patients with CIEDs such as PMs or ICDs, MRI could induce
adverse effects including tissue heating, failure of capture,
runaway PM function, unpredictable reed switch behavior, asyn-
chronous pacing, or damage to PM circuitry [4]. Consequently,
MRI is contraindicated in such patients. However, in medical
situations such as the case described here, MRI has an
Fig. 3. Cranial to cervical MRI. (A) A sagittal section of the T2-weighted image shows an apparent high-intensity region at the medulla to upper cervical spinal cord,
indicating a brainstem tumor. (B) A transverse section at the level of medulla shows partial extension of the tumor towards the fourth ventricle.
H. Furusho et al. / Journal of Arrhythmia 28 (2012) 353–355 355indispensable role in diagnosis, especially for brain and cere-
brospinal diseases, and is occasionally necessary.
In North America and Europe, the use of MRI in patients with
PMs and ICDs has been reported in some cases. Two position
statements, one from the European Society of Cardiology and the
other from the American Heart Association, guide clinicians who
are conducting MRI in patients with CIEDs [3,5]. We performed
the MRI described in the current study according to both of these
statements. We built enough consensuses among the clinicians
involved to perform MRI for this patient. We used a 1.5-Tesla MRI
machine with a maximum speciﬁc absorption rate of 2.13 W/Kg,
without taking special measures. A pulse oximeter proved very
effective in monitoring the patient’s status during MRI scanning.
We used the ODO setting for programming of the ICD device, and
no adverse events were observed. Although MRI is thought not to
induce severe adverse events when used appropriately in non-
PM-dependent patients, great care must be taken with pacing-
dependent patients. Furthermore, because rapid stimulation
events in a phantom study [3] and device resetting in a human
case [2] have been reported, patients at high risk for life-
threatening arrhythmia should be subject to particularly vigilant
supervision.
A United States Food and Drug Administration (FDA) approved
MRI-conditional PM, and some PMs and ICDs that are MRI-
conditional in the European Union, although they are not domes-
tically approved, will be available in Japan in the near future.
However, when using these devices, interrogation and repro-
gramming before and after MRI will be important; furthermore,
some characteristics of both the patient and the machinery will
continue to restrict the use of MRI in CIED patients. Moreover, to
be fully MRI-conditional, both CIED generators and leads must be
suitable for use in MRI machines; therefore, it will take some time
before CIEDs are truly compatible with MRI use.4. Conclusions
We performed cranial to cervical MRI in a patient with an ICD
who needed urgent diagnosis. As similar situations will continue
to occur in the near future, it is important to have accurate
knowledge of, and to prepare appropriate systems for, the use of
MRI in CIED-implanted patients.A summary concerning the use of MRI in such situations
follows. (1) Absolute safety of MRI in patients with an ICD of a
previous or current version cannot be guaranteed, and each case
requires a careful risk–beneﬁt evaluation. (2) Potential adverse
effects of MRI must be explained to the patient, and informed
consent must be obtained. (3) Speciﬁc absorption rate and total
active scan time, such as the length of radiofrequency exposure, is
limited according to the appropriate recommendation or scien-
tiﬁc statement, and high-risk anatomic regions with full coverage
of the lead loop must be excluded. (4) Reprogramming of the ICD
should be carried out as appropriate, including setting the pacing
mode to ODO and turning off all tachycardia detection, and a
physician with electrophysiological expertise should perform
post-scan device reprogramming. (5) Continuous monitoring of
ECG and pulse oximetry is needed. (6) MRI should be performed
under well-controlled circumstances, for example, resuscitation
facilities should be available at the MRI site.Conﬂict of interest
None.
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